meeting

Immutable Holdings Announces Voting Results for its Annual General and Special Meeting of Shareholders

December 31, 2025 18:02 ET  | Source: Immutable Holdings Inc. VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Immutable…

2 days ago

Nexteer Sponsored Automotive Chassis-by-Wire Standards Research Group Meeting, Advancing Steer-by-Wire Standards in China

AUBURN HILLS, Mich. and SUZHOU, China, Dec. 31, 2025 /PRNewswire/ -- Nexteer Automotive, a global leader in advanced steering and…

2 days ago

Inside China | Kishore Mahbubani: APEC meeting in Shenzhen could inspire global development

GUANGZHOU, China, Dec. 30, 2025 /PRNewswire/ -- News report from South:  Shenzhen recently hosted the Asia-Pacific Economic Cooperation (APEC) Informal…

3 days ago

Xinhua Silk Road: Chinese baijiu maker convenes meeting to seize chances in changing market

BEIJING, Dec. 22, 2025 /PRNewswire/ -- When disruptive changes redefined market demand in the past days of 2025, Chinese baijiu producer…

2 weeks ago

Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC

SAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…

2 weeks ago

GEDU Global Education Signs Agreement with United Nations Agency UNITAR during XXII CIFAL Annual Meeting in London

LONDON, Dec. 17, 2025 /PRNewswire/ -- UK-based education multinational GEDU Global Education has signed an agreement with the United Nations Institute…

2 weeks ago

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

December 11, 2025 18:22 ET  | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

3 weeks ago

Genmab to Hold 2025 R&D Update and ASH Data Review Meeting

Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2025 – Genmab…

3 weeks ago

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

4 weeks ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

4 weeks ago